Print

Raptor Pharmaceutical Inc. (RPTP) Announces Presentation of PROCYSBI™ (RP103) Extension Study Data at the American Society of Nephrology Annual Meeting  
10/17/2012 9:51:35 AM

NOVATO, Calif., Oct. 17, 2012 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq:RPTP), announced that Craig B. Langman, M.D., Head of Kidney Diseases, and the Isaac A. Abt, M.D., Professor of Kidney Diseases and Tenured Professor of Pediatrics, Northwestern University Feinberg School of Medicine, will present a Late Breaking Poster session titled "Extended Treatment with RP103 (PROCYSBIâ„¢) in Patients with Nephropathic Cystinosis" at Kidney Week 2012, the world's premier nephrology meeting, which is being held October 30-November 4th at the San Diego Convention Center in San Diego, California. Dr. Langman's presentation is on Saturday, November 3rd in a session beginning at 10:00 A.M. PT.
//-->